Regression of cytomegalovirus retinitis associated with protease- inhibitor treatment in patients with AIDS

American Journal of Ophthalmology

Volumn 124, Issue 2, 1997, Pages 199-205

  Reed, J B ^a   Schwab, I R ^a   Gordon, J ^a   Morse, L S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; EYE PHOTOGRAPHY; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; REMISSION; RETINITIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0030837433     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)70784-6     Document Type: Article

References (23)

1. GN Holland A Tufail MC Jordan Cytomegalovirus diseases JS Pepose GN Holland KR Williams Ocular infection and immunity 1996 Mosby St Louis 1088 1128 Chapter 81.
2. P Pertel R Hirschtick J Phair Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus J Acquir Immune Defic Syndr 5 1992 1069 1074
3. EF Bowen P Wilson M Atkins Natural history of untreated cytomegalovirus retinitis Lancet 346 1995 1671 1673
4. Studies of Ocular Complications of AIDS (SOCA) research group in collaboration with the AIDS Clinical Trials Group (ACTG). Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N Engl J Med 7 1994 1250 1261
5. JG Barlett The protease inhibitors for HIV infection Ann Intern Med 124 1996 1086 1088
6. Med Lett Drugs Ther 38 1996 35 38
7. AC Colier RW Coombs DA Schoenfeld Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine N Engl J Med 334 1996 1011 1017
8. AD Kelleher A Carr J Zuaders DA Cooper Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir J Infect Dis 173 1996 321 329
9. E Hogervorst S Jurriaans F de Wolf Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of HIV-1 p24-specific but not V3-specific antibody levels J Infect Dis 171 1995 811 821
10. BS Zingman Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir [letter] N Engl J Med 334 1996 1674 1675
11. BS Elkins GN Holland EM Opremcak Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients Ophthalmology 101 1994 499 507
12. GN Holland JD Shuler Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and -untreated patients Arch Ophthalmol 110 1992 1435 1442
13. KS Keefe WR Freeman TJ Peterson Atypical healing of cytomegalovirus retinitis: significance of persistent border opacification Ophthalmology 99 1992 1377 1384
14. DJ Damico PR Skolnik BR Kosloff Resolution of cytomegalovirus retinitis with zidovudine therapy: case report Arch Ophthalmol 106 1988 1168 1169
15. DR Guyer DA Jabs AM Brant Regression of cytomegalovirus with zidovudine: a clinicopathologic correlation Arch Ophthalmol 107 1989 868 874
16. MT Fay WR Freeman CA Wiley Atypical retinitis in patients with the acquired immunodeficiency syndrome Am J Ophthalmol 105 1988 483 490
17. P Kaulen DT Pham E Baranowski J Wollensak Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection Ger J Ophthalmol 2 1993 412 415
18. H Masur SM Whitcup C Cartwright Advances in the management of AIDS-related cytomegalovirus retinitis Ann Intern Med 125 1996 126 136
19. PR Egbert RB Pollard JG Gallagher TC Merigan Cytomegalovirus retinitis in immunosuppressed hosts, II: ocular manifestations Ann Intern Med 93 1980 664 670
20. M Markowitz H Ho DJ Kempf Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor J Virol 69 1995 701 706
21. SA Danner A Carr JM Leonard A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease N Engl J Med 333 1995 1528 1533
22. M Markowitz M Saag WG Powderly A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection N Engl J Med 333 1995 1534 1539
23. MB Feinberg Changing the natural history of HIV disease Lancet 348 1996 239 246